Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Assumptions & Limitations
2.1.1 Assumptions
2.1.2 Limitations
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Trade Analysis
3.5 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing demand for diagnosis of chronic disease
4.2.2 Rising prevalence of diabetes leading to high demand of lancets
4.2.3 Favorable Medical Device Regulation
4.2.4 Increasing Geriatric Population
4.3 Restraint
4.3.1 Risk Associated With Capillary Blood Assortment Techniques and Blood Contaminations
4.4 Opportunity
4.4.1 Technological advancement
4.5 Megatrend
4.6 Macroeconomic Indicators
5 Market Impact Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply chain analysis
5.2.1 R&D
5.2.2 Parts Manufacturing
5.2.3 Distribution
5.2.4 Marketing & Sales
5.2.5 Post-Sales Monitoring
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunities
6 Global Capillary Blood Collection Devices Market by Material
6.1 Introduction
6.1.1 Plastic
6.1.2 Glass
6.1.3 Stainless Steel
7 Global Capillary Blood Collection Devices Market by Type of Devices
7.1 Introduction
7.1.1 Blood Collecting Tubes and Collector
7.1.2 Lancets
7.1.3 Warming Devices
8 Global Capillary Blood Collection Devices Market by End-User
8.1 Introduction
8.1.1 Hospitals & Clinics
8.1.2 Diagnostic Centres and Pathology Laboratories
8.1.3 Home Diagnostics
9 Global Capillary Blood Collection Devices Market by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of Middle East & Africa
10 Company Landscape
10.1 Company Market Share Analysis
10.1.1 Introduction
10.2 Competitive Strategies
10.2.1 Introduction
11 Company Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 Danaher Corporation
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 Novo Nordisk A S
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 Becton Dickinson
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 Medtronic PLC
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 B. Braun Melsungen AG
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Products
11.8.4 Strategy
11.8.5 Key Developments
11.9 Terumo Corporation
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Products
11.9.4 Strategy
11.9.5 Key Developments
11.1 Ypsomed Holding AG
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Products
11.10.4 Strategy
11.10.5 Key Developments
11.11 HTL-STREFA S.A.
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Products
11.11.4 Strategy
11.11.5 Key Developments
11.12 Sarstedt AG & Co
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Products
11.12.4 Strategy
11.12.5 Key Developments
11.13 Owen Mumford Ltd.
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Products
11.13.4 Strategy
11.13.5 Key Developments
11.14 Greiner Bio One
11.14.1 Company Overview
11.14.2 Financials
11.14.3 Products
11.14.4 Strategy
11.14.5 Key Developments
11.15 Improve Medical
11.15.1 Company Overview
11.15.2 Financials
11.15.3 Products
11.15.4 Strategy
11.15.5 Key Developments
12 Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
12.2 Key Companies to Watch
13 Appendix
13.1 Discussion Blue Print
13.1 Recent Developments, 2014-2017